IDO positivity has been indeed demonstrated in human tumors of different histology, such as colon and ovarian cancers, melanoma, and leukemia (72), and it is expressed by tumor cells (73), endothelial cells (74), and infiltrating immune cells, mainly APCs, DCs, and TAMs contributing to immune suppression (68, 75). This evidence concerns the gene IDO1 and neoplasm.